{"id":3959,"date":"2017-08-13T11:10:59","date_gmt":"2017-08-13T11:10:59","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/2nd-world-congress-integrative-medicine\/"},"modified":"2026-02-17T11:53:14","modified_gmt":"2026-02-17T11:53:14","slug":"kongress-integrativ-medisin-hypertermi","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/no\/kongress-integrativ-medisin-hypertermi\/","title":{"rendered":"2. verdenskongress om integrativ medisin &#8211; dr. G. Fiorentini Ph.D. &#8211; presentasjon om hypertermi"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"MedicalWebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/no\/kongress-integrativ-medisin-hypertermi\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/no\/kongress-integrativ-medisin-hypertermi\/\",\n      \"name\": \"Prof. Dr. Giammaria Fiorentini: Globalt vitenskapelig lederskap og mHT kliniske studier\",\n      \"description\": \"Utforsk den kliniske portef\u00f8ljen og mHT (modulert elektro-hypertermi) forskning av Prof. Dr. Giammaria Fiorentini. Multisenterstudier p\u00e5 bukspyttkjertelkreft og glioblastom.\",\n      \"inLanguage\": \"nb-NO\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"publisher\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \"mainEntity\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/no\/kongress-integrativ-medisin-hypertermi\/#fiorentini\" },\n      \"about\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/no\/kongress-integrativ-medisin-hypertermi\/#fiorentini\" },\n        { \"@type\": \"MedicalProcedure\", \"name\": \"Modulert elektro-hypertermi (mHT)\" }\n      ]\n    },\n    {\n      \"@type\": \"Person\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/no\/kongress-integrativ-medisin-hypertermi\/#fiorentini\",\n      \"name\": \"Prof. Dr. Giammaria Fiorentini\",\n      \"jobTitle\": \"Medlem av vitenskapelig r\u00e5d (SRHO & SIIO), ESHO-medlem\",\n      \"sameAs\": [\n        \"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Fiorentini+G\",\n        \"https:\/\/scholar.google.com\/scholar?q=Giammaria+Fiorentini\"\n      ],\n      \"knowsAbout\": [\"Onkologisk hypertermi\", \"Integrativ onkologi\", \"Klinisk mHT-forskning\"],\n      \"workExample\": [\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"Hypertermi kombinert med cellegift vs. cellegift hos pasienter med avansert bukspyttkjertelkreft (2023)\",\n          \"identifier\": \"PMID: 37398545\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"Modulert elektro-hypertermi i stadium III og IV bukspyttkjertelkreft: Resultater p\u00e5 158 pasienter (2021)\",\n          \"identifier\": \"PMID: 34909400\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"mHT i integrativ kreftbehandling for residiverende malignt glioblastom og astrocytom (2019)\",\n          \"identifier\": \"PMID: 30580645\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"Quo Vadis onkologisk hypertermi? (2020)\",\n          \"identifier\": \"PMID: 33014841\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"En fase II klinisk studie p\u00e5 residiverende maligne gliomer behandlet med elektro-hypertermi (2006)\",\n          \"identifier\": \"PMID: 17203754\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"Modulert elektro-hypertermi som palliativ behandling: 106 pasienter (2019)\",\n          \"identifier\": \"PMID: 31561722\"\n        }\n      ]\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/\",\n      \"logo\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/Andromedic-Logo.jpg\"\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"line-height: 1.6; color: #333; max-width: 1100px; margin: auto; font-family: 'Segoe UI', Helvetica, sans-serif; background-color: #fff; padding: 20px;\">\n<header style=\"border-bottom: 4px solid #1a2a6c; padding-bottom: 25px; margin-bottom: 40px; text-align: center;\">\n<h1 style=\"color: #1a2a6c; font-size: 28px; font-weight: 800; text-transform: uppercase; margin-bottom: 10px;\">Global fortreffelighet innen integrativ onkologi: ICIM Roma 2023<\/h1>\n<h2 style=\"color: #b21f1f; font-size: 20px; font-weight: 600;\">Vitenskapelig samarbeid med prof. dr. Giammaria Fiorentini<\/h2>\n<p style=\"font-size: 16px; max-width: 850px; margin: 15px auto; color: #555;\"><strong>Imunomedica<\/strong>-teamet (dr. Virgiliu Vlaescu George, <a style=\"color: #1a2a6c; text-decoration: underline;\" href=\"https:\/\/andromedichyperthermia.com\/cristian-gologan\/\">Cristian Gologan M.Sc<\/a>., <a style=\"color: #1a2a6c; text-decoration: underline;\" href=\"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-veronica-iatan\/\">dr. Veronica Iatan<\/a>, dr. Laurentiu Broscaru) deltok p\u00e5 den 2. verdenskongressen for integrativ medisin, og konsoliderte protokoller for onkologisk hypertermi p\u00e5 h\u00f8yeste globale niv\u00e5.<\/p>\n<\/header>\n<div style=\"display: flex; flex-wrap: wrap; justify-content: center; gap: 20px; margin-bottom: 50px; background: linear-gradient(135deg, #1a2a6c, #b21f1f); padding: 35px; border-radius: 15px; color: #fff; text-align: center; box-shadow: 0 10px 25px rgba(0,0,0,0.15);\">\n<div style=\"flex: 1; min-width: 200px;\"><span style=\"font-size: 45px; font-weight: 800; display: block;\">357<\/span><span style=\"text-transform: uppercase; font-size: 13px; letter-spacing: 1.5px; font-weight: 600;\">PubMed-studier<\/span><\/div>\n<div style=\"flex: 1; min-width: 200px;\"><span style=\"font-size: 45px; font-weight: 800; display: block;\">20+<\/span><span style=\"text-transform: uppercase; font-size: 13px; letter-spacing: 1.5px; font-weight: 600;\">Behandlede krefttyper<\/span><\/div>\n<div style=\"flex: 1; min-width: 200px;\"><span style=\"font-size: 45px; font-weight: 800; display: block;\">ESHO<\/span><span style=\"text-transform: uppercase; font-size: 13px; letter-spacing: 1.5px; font-weight: 600;\">Elite medisinsk ekspertise<\/span><\/div>\n<\/div>\n<div style=\"display: flex; flex-direction: column; align-items: center; gap: 30px; margin-bottom: 50px;\">\n<div style=\"width: 100%; max-width: 850px; text-align: center;\">\n<p><img loading=\"lazy\" decoding=\"async\" width=\"799\" height=\"571\" class=\"wp-image-502\" style=\"width: 100%; border-radius: 15px; box-shadow: 0 8px 20px rgba(0,0,0,0.1);\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/icim-2023.jpg\" alt=\"Imunomedica-teamet i Roma 2023 \u2013 onkologisk hypertermi\" title=\"\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/icim-2023.jpg 799w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/icim-2023-300x214.jpg 300w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/icim-2023-768x549.jpg 768w\" sizes=\"auto, (max-width: 799px) 100vw, 799px\" \/><\/p>\n<p style=\"font-size: 14px; color: #666; margin-top: 10px; font-style: italic;\">Sertifisering for klinisk ekspertise innen hypertermi \u2013 Cristian Gologan M.Sc.<\/p>\n<\/div>\n<div style=\"width: 100%; max-width: 850px; text-align: center;\">\n<p><img decoding=\"async\" class=\"wp-image-503\" style=\"width: 100%; border-radius: 15px; box-shadow: 0 8px 20px rgba(0,0,0,0.1);\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/2nd-world-congress-of-integrative-medicine-and-health-rome-2023.jpg\" alt=\"Den 2. verdenskongressen i Roma 2023\" title=\"\"><\/p>\n<p style=\"font-size: 14px; color: #666; margin-top: 10px; font-style: italic;\">ICIM Roma plenumssesjon \u2013 Fremtiden for integrativ onkologisk medisin.<\/p>\n<\/div>\n<\/div>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; padding: 35px; border-radius: 15px; background-color: #f9f9f9;\">\n<h3 style=\"color: #1a2a6c; border-bottom: 3px solid #b21f1f; display: inline-block; padding-bottom: 5px; margin-bottom: 20px;\">Globalt vitenskapelig lederskap<\/h3>\n<p style=\"font-size: 17px; margin-bottom: 20px;\"><strong>Prof. dr. Giammaria Fiorentini<\/strong> er et produktivt medlem av <a style=\"color: #b21f1f; text-decoration: none; font-weight: bold;\" href=\"http:\/\/esho.info\" target=\"_blank\" rel=\"noopener\">ESHO (European Society for Hyperthermic Oncology)<\/a> og et aktivt medlem av det vitenskapelige r\u00e5det (SAB) for <strong>SRHO<\/strong> og <strong>SIIO<\/strong>. V\u00e5rt direkte samarbeid garanterer pasienter tilgang til kliniske resultater validert av mer enn 350 publiserte artikler.<\/p>\n<div style=\"background: #1a2a6c; padding: 20px; border-radius: 10px; text-align: center;\"><a style=\"color: #fff; text-decoration: none; font-weight: 800; font-size: 18px;\" href=\"http:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/WS-G-Giorentini-20-sept-2023-room-9-Rome-hyperthermia-x-gologan.pdf\"> LAST NED: Klinisk oversikt og kasusrapporter (PDF)<\/a><\/div>\n<\/section>\n<div style=\"background: #f0f4f8; padding: 30px; border-radius: 15px; margin-bottom: 50px; text-align: center; border: 1px solid #d1d9e6;\">\n<h4 style=\"color: #1a2a6c; margin-bottom: 25px; text-transform: uppercase;\">Virkningsmekanisme dokumentert i prof. Fiorentinis forskning<\/h4>\n<div style=\"display: flex; flex-wrap: wrap; justify-content: space-around; align-items: center; gap: 20px; margin-top: 20px;\">\n<div style=\"flex: 1; min-width: 250px; background: #fff; padding: 20px; border-radius: 10px; border-top: 5px solid #b21f1f;\">\n<p><span style=\"font-size: 24px; display: block; margin-bottom: 10px;\"> 13.56 MHz<\/span><\/p>\n<p style=\"font-size: 14px; margin: 0;\"><b>Selektivitet:<\/b> Radiob\u00f8lger identifiserer maligne celler p\u00e5 grunn av deres h\u00f8ye elektriske ledningsevne.<\/p>\n<\/div>\n<div style=\"flex: 1; min-width: 250px; background: #fff; padding: 20px; border-radius: 10px; border-top: 5px solid #b21f1f;\">\n<p><span style=\"font-size: 24px; display: block; margin-bottom: 10px;\"> Termisk stress<\/span><\/p>\n<p style=\"font-size: 14px; margin: 0;\"><b>Apoptose:<\/b> M\u00e5lrettet varme induserer destruksjon av kreftceller uten \u00e5 p\u00e5virke friskt vev.<\/p>\n<\/div>\n<div style=\"flex: 1; min-width: 250px; background: #fff; padding: 20px; border-radius: 10px; border-top: 5 solid #b21f1f;\">\n<p><span style=\"font-size: 24px; display: block; margin-bottom: 10px;\">&#xfe0f; Immunitet<\/span><\/p>\n<p style=\"font-size: 14px; margin: 0;\"><b>Abskopal effekt:<\/b> Forberedelse av immunsystemet til \u00e5 gjenkjenne og angripe systemiske maligne celler.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<h3 style=\"color: #1a2a6c; border-left: 6px solid #b21f1f; padding-left: 15px; margin-bottom: 30px;\">Viktige kliniske referanser: prof. Giammaria Fiorentini<\/h3>\n<div style=\"display: grid; grid-gap: 20px;\">\n<div style=\"padding: 20px; border: 1px solid #e1e8ed; border-radius: 8px; background: #fff; border-top: 4px solid #b21f1f;\">\n<p><strong style=\"font-size: 17px; display: block; margin-bottom: 10px;\">[2023] Hypertermi kombinert med kjemoterapi vs kjemoterapi hos pasienter med avansert bukspyttkjertelkreft.<\/strong><\/p>\n<p style=\"font-size: 15px;\">En multisenter sammenlignende studie som viser en \u00f8kning i median overlevelse fra 9 til 20 m\u00e5neder gjennom integrering av mHT.<\/p>\n<p><small style=\"color: #666;\"><strong>Forfatter: Fiorentini G<\/strong>, et al. | World J Clin Oncol. PMID: 37398545<\/small><\/p>\n<\/div>\n<div style=\"padding: 20px; border: 1px solid #e1e8ed; border-radius: 8px; background: #fff; border-top: 4px solid #b21f1f;\">\n<p><strong style=\"font-size: 17px; display: block; margin-bottom: 10px;\">[2021] Modulert elektro-hypertermi ved bukspyttkjertelkreft stadium III og IV: Resultater hos 158 pasienter.<\/strong><\/p>\n<p style=\"font-size: 15px;\">Observasjonsanalyse p\u00e5 en av de st\u00f8rste pasientkohortene, som bekrefter tumorkontroll i avanserte stadier.<\/p>\n<p><small style=\"color: #666;\"><strong>Forfatter: Fiorentini G<\/strong>, et al. | World J Clin Oncol. PMID: 34909400<\/small><\/p>\n<\/div>\n<div style=\"padding: 20px; border: 1px solid #e1e8ed; border-radius: 8px; background: #fff; border-top: 4px solid #b21f1f;\">\n<p><strong style=\"font-size: 17px; display: block; margin-bottom: 10px;\">[2019] mHT i integrativ kreftbehandling for residiverende malignt glioblastom og astrocytom.<\/strong><\/p>\n<p style=\"font-size: 15px;\">Kontrollert multisenterstudie p\u00e5 pasienter med hjernerecidiv, som validerer sikkerhet og livsforlengelse.<\/p>\n<p><small style=\"color: #666;\"><strong>Forfatter: Fiorentini G<\/strong>, et al. | Integr Cancer Ther. PMID: 30580645<\/small><\/p>\n<\/div>\n<div style=\"padding: 20px; border: 1px solid #e1e8ed; border-radius: 8px; background: #f4f7f9; border-top: 4px solid #1a2a6c;\">\n<p><strong style=\"font-size: 17px; display: block; margin-bottom: 10px;\">[2020] Quo Vadis onkologisk hypertermi?<\/strong><\/p>\n<p style=\"font-size: 15px;\">En banebrytende oversikt som redefinerer onkologisk hypertermi, og understreker den nanoskopiske selektiviteten til maligne celler.<\/p>\n<p><small style=\"color: #666;\"><strong>Medforfatter: Fiorentini G<\/strong> | Front Oncol. PMID: 33014841<\/small><\/p>\n<\/div>\n<\/div>\n<div style=\"text-align: center; margin-top: 40px; padding: 25px; border: 2px dashed #1a2a6c; border-radius: 10px; background-color: #fcfcfc;\">\n<p style=\"font-weight: bold; margin-bottom: 15px;\">Utforsk prof. Fiorentinis fullstendige forskningsportef\u00f8lje:<\/p>\n<p><a style=\"display: inline-block; background: #b21f1f; color: #fff; padding: 14px 30px; text-decoration: none; border-radius: 5px; font-weight: 800; text-transform: uppercase;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Fiorentini+G\" target=\"_blank\" rel=\"noopener\">SE ALLE 357 RESULTATER P\u00c5 PUBMED<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Global fortreffelighet innen integrativ onkologi: ICIM Roma 2023 Vitenskapelig samarbeid med prof. dr. Giammaria Fiorentini Imunomedica-teamet (dr. Virgiliu Vlaescu George, Cristian Gologan M.Sc., dr. Veronica Iatan, dr. Laurentiu Broscaru) deltok p\u00e5 den 2. verdenskongressen for integrativ medisin, og konsoliderte protokoller for onkologisk hypertermi p\u00e5 h\u00f8yeste globale niv\u00e5. 357PubMed-studier 20+Behandlede krefttyper ESHOElite medisinsk ekspertise Sertifisering for&hellip;<\/p>\n","protected":false},"author":1,"featured_media":2533,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3959","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/pages\/3959","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/comments?post=3959"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/pages\/3959\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/media\/2533"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/media?parent=3959"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}